Our discovery that both genomic PRAME deletion and EZH2 mutations converge on reduced PRAME expression and downstream phenotypes underscores the pathogenic relevance of the PRAME gene in B cell lymphoma. Here, PRAME is linked to B-cell non-Hodgkin lymphoma.